Skip to main content

Table 1 Symptoms developed in patients after 12 weeks of treatment

From: Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study

Characteristic

Negative

Positive

HCV 1a (n=10)

 Lethargy

6

2

 Headache

8

0

 Nausea

4

4

 Diarrhoea

6

2

 Dizziness

6

2

 Shortness of breath

7

1

 Insomnia

5

3

 Arthralgia

4

4

 Mood disturbances

4

4

HCV 1b (n=2)

 Lethargy

1

1

 Headache

1

1

 Nausea

1

1

 Diarrhoea

0

2

 Dizziness

2

0

 Shortness of breath

2

0

 Insomnia

2

0

 Arthralgia

1

1

 Mood disturbances

2

0

HCV 4 (n=8)

 Lethargy

5

1

 Headache

6

0

 Nausea

4

2

 Diarrhoea

5

1

 Dizziness

4

2

 Shortness of breath

6

0

 Insomnia

4

2

 Arthralgia

3

3

 Mood disturbances

4

2

HCV 5 (n=1)

 Lethargy

1

0

 Headache

1

0

 Nausea

1

0

 Diarrhoea

1

0

 Dizziness

1

0

 Shortness of breath

1

0

 Insomnia

1

0

 Arthralgia

1

0

 Mood disturbances

1

0